First-degree relatives experienced an MS incidence of 211 per 100,000 per year, roughly 100-fold above sporadic MS rates, with median 2-year time to conversion and diagnosis at 37. Evolving ...
The efficacy and safety of furmonertinib in patients with advanced EGFR-mutated NSCLC and leptomeningeal metastases. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Overall, specific lipids and amino acids were indicated as the most common metabolite classes associated with breast cancer development. However, comparison of results across studies is challenging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results